Yuzhe Liu is a Chicago, Illinois based neurologist who is specialized in Neurology. Active license number of Yuzhe Liu is 125.076009 for Neurology in Illinois. His current practice location is 251 E Huron St, Chicago. Patients can reach him at 312-926-2000. Yuzhe Liu is MD, PHD in Neurology and his NPI number (Unique professional ID assigned by NPPES) is 1811524879. Yuzhe Liu specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Yuzhe Liu speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
Name:
Yuzhe Liu
Specialization:
Neurology
Gender:
Male
Credentials:
MD, PHD
Practice Address:
251 E Huron St, Chicago, Illinois, 60611-2908
Phone:
312-926-2000
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1811524879
NPI Enumeration Date:
26 Mar, 2020
NPI Last Update On:
15 Jun, 2020
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Yuzhe Liu are as mentioned below.
License Number
Specialization
State
Status
125.076009
Neurology
Illinois
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Yuzhe Liu 251 E Huron St, Chicago, Illinois
Zip:
60611-2908
Patients can reach Yuzhe Liu at 251 E Huron St, Chicago, Illinois or can call to book an appointment on 312-926-2000.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.